著作發表

原著論文（第一作者）

1. Ling LC, Lo LW, Chung FP, et al. Skin sympathetic nerve activity after pulsed field pulmonary vein isolation for paroxysmal atrial fibrillation: the NEU-PFA Study. Circ Arrhythm Electrophysiol. 2026;19(9):e015148. doi:10.1161/CIRCEP.126.015148. PMID:42743271.（Research Letter，open access）
2. Ling LC, Chang TY, Lee CH, et al. Predictors of recurrence and quality of life after cryoballoon ablation in atrial fibrillation: data from a multicenter Taiwanese registry with 24-month follow-up. J Cardiovasc Electrophysiol. 2026. doi:10.1111/jce.70518. PMID:42836688.（線上先行）
3. Ling LC, Huang WM, Chang HC, et al. Change in dapagliflozin trial eligibility status and prognosis among patients with acute heart failure with preserved ejection fraction. J Chin Med Assoc. 2026;89(3):220-227. doi:10.1097/JCMA.0000000000001349. PMID:41630103.
4. Ling LC, Chang TY, Lin CY, et al. Impact of obesity phenotypes on efficacy and safety of catheter ablation for patients with paroxysmal atrial fibrillation. Acta Cardiol Sin. 2025;41(6):691-702. doi:10.6515/ACS.202511_41(6).20250616E. PMID:41311576.
5. Ling LC, Lin CY, Lin YJ. Epicardial mapping and ablation of ventricular tachycardia in a patient with non-ischemic cardiomyopathy post-thoracotomy cardiovascular surgery and epicardial pacemaker implantation: a case report of challenges. Acta Cardiol Sin. 2025;41(6):800-804. doi:10.6515/ACS.202511_41(6).20250818B. PMID:41311574.
6. Ling LC, Chang TY, Lin YJ, et al. Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure. J Arrhythm. 2024;40(6):1359-1369. doi:10.1002/joa3.13162. PMID:39669923.

原著論文（共同作者）

1. Lee CC, Lin CY, Chung FP, … Ling LC, … Chen SA. Utilizing lead aVR QRS morphology to localize abnormal substrates in arrhythmogenic right ventricular cardiomyopathy. Korean Circ J. 2027;57(1):e14. doi:10.4070/kcj.2025.0547.（線上先行）
2. Le XH, Lin CY, Chung FP, … Ling LC, … Chen SA. Premature ventricular contractions from the proximal left anterior fascicle: insight from the electrophysiologic and anatomic parameters. J Cardiovasc Electrophysiol. 2026;37(1):7-16. doi:10.1111/jce.70164. PMID:41146413.
3. Lin CY, et al.（Ling LC 共同作者）. Islands of fractionation for automated fractionation mapping in epicardial Brugada syndrome substrate ablation. Pacing Clin Electrophysiol. 2026.（已接受，in press）

學會摘要（第一作者，11 篇）

• Electrode-spacing–dependent near-field–far-field local activation time difference as a marker of intramural / LVOT PVCs. APSC 2026 — Best Moderated Poster Award得獎
• Post-procedural troponin I surge as a predictor of atrial arrhythmia recurrence after PFA. 台灣心律醫學會（THRS）2026 — Chaired Poster 第三名得獎
• Early recurrence of atrial tachyarrhythmia during the 8-week blanking period after PFA predicts late recurrence: a multicenter registry. Heart Rhythm. 2026;23(4):S223-S224.（HRS 2026）
• Assessment of sympathetic neural activity post-pulsed field ablation: findings from a paroxysmal AF cohort（the NEU-PFA trial）. Heart Rhythm. 2025;22(4):S242.（HRS 2025）
• Modified olive strategy enhances pentaspline PFA outcomes in paroxysmal AF: a multicenter prospective cohort registry. Heart Rhythm. 2025;22(4):S346-S347.（HRS 2025）
• Impact of obesity phenotypes on atrial fibrillation ablation outcomes in an Asian population. Heart Rhythm. 2025;22(4):S351-S352.（HRS 2025）
• Cardiovascular mortality increased in atrial fibrillation patients with high level of physical activity: delineating the threshold of high-level. Heart Rhythm. 2025;22(4):S216-S217.（HRS 2025）
• Longitudinal outcomes of ablation therapy for paroxysmal atrial fibrillation in Asian populations with metabolically distinct obesity profiles. Heart Rhythm. 2024;21(5):S342-S343.（HRS 2024）
• Asymptomatic left ventricular dysfunction in patients with or without type 2 diabetes mellitus: a population-based cohort study. J Am Coll Cardiol. 2023;81(16):S48-S49. TCTAP 2023 — Best Abstract Award得獎
• Outcomes of asymptomatic left ventricular dysfunction in the patient with or without type 2 diabetes mellitus. Eur Heart J. 2023;44(Suppl 2):ehad655.835.（ESC Congress 2023）
• The classification shifting and outcomes of DELIVER-type patients with acute heart failure and preserved ejection fraction. Eur Heart J. 2023;44(Suppl 2):ehad655.1098.（ESC Congress 2023）

學會摘要（共同作者，21 篇，節錄）

• Increased PFA applications lead to greater myocardial injury, inflammation and hemolysis without affecting cardiac autonomic neuron activity. Heart Rhythm. 2025;22(4):S388-S389.（第二作者，HRS 2025）
• PFA reduces AF recurrence without inducing autonomic neural remodeling in the LA. Heart Rhythm. 2025;22(4):S390.（第二作者，HRS 2025）
• 其餘為 HRS 2024–2026 與 EHRA 2024（Europace）共同作者摘要，以心房顫動 PFA、心室頻脈與 Brugada 症候群系列為主。

審稿中

• Modified 4-application olive workflow for pentaspline pulsed-field pulmonary vein isolation in paroxysmal AF（OLIVE-PFA Study，多中心）。
• Cardiovascular mortality in patients with AF and physical activity intensity（vigorous-activity threshold）。

中文文章

• 凌濼傑、李慶威。主動脈瓣狹窄之介紹與現行治療指引——根據美國及歐洲心臟醫學會發佈之治療指引。臨床醫學月刊. 2023;91(1):42-47.